Pharma Mar SAU
Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis, a syntheti… Read more
Pharma Mar SAU (PHMMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.083x
Based on the latest financial reports, Pharma Mar SAU (PHMMF) has a cash flow conversion efficiency ratio of 0.083x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.71 Million) by net assets ($202.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharma Mar SAU - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Pharma Mar SAU's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharma Mar SAU Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharma Mar SAU ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Winmark Corporation
NASDAQ:WINA
|
-0.465x |
|
Ferrotec Corporation
F:FER
|
N/A |
|
Huada Automotive Tech Corp Ltd
SHG:603358
|
-0.009x |
|
Port of Tauranga Limited
OTCGREY:PTAUF
|
0.016x |
|
Guangdong Baolihua New Energy Stock Co LTD
SHE:000690
|
0.014x |
|
SO.NA.GA.N.R.GDR REGS LN1
F:RZ8G
|
N/A |
|
China Southern Power Grid Technology Co Ltd
SHG:688248
|
0.025x |
|
Hydsoft Technology Co. Ltd. A
SHE:301316
|
N/A |
Annual Cash Flow Conversion Efficiency for Pharma Mar SAU (2002–2024)
The table below shows the annual cash flow conversion efficiency of Pharma Mar SAU from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $208.36 Million | $6.03 Million | 0.029x | +141.61% |
| 2023-12-31 | $193.44 Million | $-13.45 Million | -0.070x | -140.44% |
| 2022-12-31 | $222.96 Million | $38.32 Million | 0.172x | +19.09% |
| 2021-12-31 | $177.92 Million | $25.68 Million | 0.144x | -94.69% |
| 2020-12-31 | $102.72 Million | $278.94 Million | 2.716x | +177.46% |
| 2019-12-31 | $7.46 Million | $-26.14 Million | -3.505x | -274.86% |
| 2018-12-31 | $17.47 Million | $-16.34 Million | -0.935x | -1373.18% |
| 2017-12-31 | $22.98 Million | $-1.46 Million | -0.063x | +63.41% |
| 2016-12-31 | $48.49 Million | $-8.41 Million | -0.174x | -214.15% |
| 2015-12-31 | $73.04 Million | $11.10 Million | 0.152x | -58.70% |
| 2014-12-31 | $60.07 Million | $22.11 Million | 0.368x | +11.32% |
| 2013-12-31 | $49.44 Million | $16.34 Million | 0.331x | +102.63% |
| 2012-12-31 | $38.73 Million | $6.32 Million | 0.163x | +231.48% |
| 2011-12-31 | $34.50 Million | $-4.28 Million | -0.124x | +80.24% |
| 2010-12-31 | $34.86 Million | $-21.90 Million | -0.628x | -14.01% |
| 2009-12-31 | $41.14 Million | $-22.67 Million | -0.551x | +23.75% |
| 2008-12-31 | $49.34 Million | $-35.66 Million | -0.723x | -45.25% |
| 2007-12-31 | $98.81 Million | $-49.16 Million | -0.497x | +4.99% |
| 2006-12-31 | $107.17 Million | $-56.11 Million | -0.524x | -470.66% |
| 2005-12-31 | $360.04 Million | $-33.03 Million | -0.092x | +80.98% |
| 2003-12-31 | $139.28 Million | $-67.18 Million | -0.482x | -125.85% |
| 2002-12-31 | $166.90 Million | $-35.64 Million | -0.214x | -- |